Serological bone markers and joint damage in early polyarthritis

Area of Science:

• Rheumatology
• Bone Metabolism
• Radiology

Background:

• Osteocalcin (OC) is a bone formation marker, while beta-C-telopeptide (beta-CTx) is a newer serum marker for bone resorption.
• Early inflammatory arthritis, including oligo- and polyarthritis, involves significant bone remodeling and damage.

Purpose of the Study:

• To investigate the relationship between OC, beta-CTx, and radiographic damage in early arthritis patients.
• To assess the predictive value of these bone turnover markers for radiographic progression.

Main Methods:

• A cohort of 279 patients with peripheral arthritis and symptom duration under 2 years was studied.
• Serum OC and beta-CTx levels were correlated with disease activity and radiographic damage at baseline and after 2 years.
• Multivariate logistic regression analyzed the additional value of bone markers compared to established prognostic factors.

Main Results:

• Baseline beta-CTx, but not OC, significantly correlated with radiographic damage and disease activity markers (ESR, CRP, DAS28).
• Increased baseline beta-CTx levels were associated with radiographic progression over 2 years.
• In multivariate analysis, beta-CTx did not offer superior prediction of radiographic progression compared to autoantibodies and disease activity measures.

Conclusions:

• Elevated serum beta-CTx levels are linked to radiographic damage and progression in early inflammatory arthritis.
• Despite associations, beta-CTx is not more predictive of radiographic progression than currently used prognostic markers in this patient group.